Spinal tanycytic ependymoma associated with neurofibromatosis type 2 - Case report

Neurologia Medico-Chirurgica

Volumn 41, Issue 10, 2001, Pages 513-516

  Ueki, K ^a   Sasaki, T ^a   Ishida, T ^a   Kirino, T ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Chromosome 22; Neurofibromatosis type 2; Spinal tumor; Tanycytic ependymoma

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN S 100;

ADOLESCENT; ANAMNESIS; ARTICLE; CASE REPORT; CELL JUNCTION; COCHLEAR NERVE; DISEASE ASSOCIATION; EPENDYMOMA; FEMALE; HISTOPATHOLOGY; HUMAN; NEUROFIBROMATOSIS; SPINAL CORD TUMOR; ULTRASTRUCTURE;

ADOLESCENT; ANTIGENS, SURFACE; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 22; EPENDYMOMA; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROFIBROMATOSIS 2; S100 PROTEINS; SPINAL CORD NEOPLASMS;

EID: 0034752659     PISSN: 04708105     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.41.513     Document Type: Article

References (9)

1. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas
2. Exon scanning for mutation of the NF2 gene in schwannomas
3. Pathologic features of ependymoma: Histological pattern and a review of the literature
4. Tanycytic ependymoma
5. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
6. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas
7. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor